Clinical Trial

Does Recessive Optic Atrophy Due to WFS1 Exist?

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
All patients with Wolfram syndrome and recessive optic atrophy due to a mutation of the WFS1 from a single Center were included in a retrospective study. Evolution of the visual acuity since the occurrence of the optic atrophy and its last value, OCT data, genetic data and systemic manifestations were analyzed.
Trial Details
NCT Number NCT07336966
Lead Sponsor Hôpital Necker-Enfants Malades
Conditions Wolfram Syndrome 1, Optic Atrophies, Hereditary
Enrollment 45 participants
Start Date 2026-02
Primary Completion 2026-03 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-13